2018
DOI: 10.1038/s41572-018-0041-4
|View full text |Cite|
|
Sign up to set email alerts
|

Multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
814
0
22

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 883 publications
(842 citation statements)
references
References 349 publications
6
814
0
22
Order By: Relevance
“…MS is a chronic autoimmune disease characterized by inflammation, demyelination, and axonal degeneration in the CNS (Correale, Gaitan, Ysrraelit, & Fiol, 2017;Filippi et al, 2018). Several strong lines of evidence point to a role for Notch in cellular processes critical for MS.…”
Section: Oligodendrocytes and Msmentioning
confidence: 99%
“…MS is a chronic autoimmune disease characterized by inflammation, demyelination, and axonal degeneration in the CNS (Correale, Gaitan, Ysrraelit, & Fiol, 2017;Filippi et al, 2018). Several strong lines of evidence point to a role for Notch in cellular processes critical for MS.…”
Section: Oligodendrocytes and Msmentioning
confidence: 99%
“…Multiple sclerosis (MS) is a chronic auto-inflammatory demyelinating disease, in which nerves are damaged by demyelination in the CNS [79]. MS patients show abnormalities in motor function, muscle weakness, and sensorimotor dysfunction [80].…”
Section: Multiple Sclerosismentioning
confidence: 99%
“…Multiple sclerosis (MS) is a leading cause of neurological disability in young adults, affecting more than 2.3 million people worldwide 1 . The pathology of MS is characterized by the periodic disruption of the blood-brain barrier and infiltration of immune cells, including T cells, B cells and macrophages, into the central nervous system (CNS) resulting in demyelination, neuroaxonal degeneration and neurological deficits.…”
Section: Introductionmentioning
confidence: 99%